Grilled Cheese

ExploreLog inSign up
Terms of UsePrivacy PolicyCommunity StandardsHelpGet the app

Grilled Cheese is a product of Village Compute

Version devBuilt at: 2026-10-10 20:13:24 EDT

Explore

PostsPeople
LatestRanked
@gmj-georgia.bsky.socialOct 10, 2026, 11:26 AM

New research reveals oxalate accumulation in chronic kidney disease drives systemic inflammation and heart damage—a mechani… #Cardiovasculardisease #Chronickidneydisease #Kidneyfunction #Oxalatemetabolism #Systemicinflammation #Cardiovasculardisease #Chronickidneydisease #Kidneyfunction #Oxalat…

@jamacardiology.comOct 10, 2026, 11:00 AM

📊 Meta-analysis: In adults with and without #ChronicKidneyDisease, intensive blood pressure lowering reduced major cardiovascular events by 15% per 10-mm Hg lower systolic blood pressure.

ja.ma/4s03YdN

JAMA Cardiology original investigation: "Intensive vs Standard Blood Pressure Lowering in People With and Without Chronic Kidney Disease: A Systematic Review and Meta-Analysis." Authors include Fotini Iatridi, Alistair J. Roddick, Natalie Staplin, and others.
@jamacardiology.comOct 7, 2026, 4:11 PM

Meta-analysis: In adults with and without #ChronicKidneyDisease, intensive blood pressure lowering reduced major cardiovascular events by 15% per 10-mm Hg lower systolic blood pressure.

ja.ma/4hxhSAp

JAMA Cardiology original investigation: "Intensive vs Standard Blood Pressure Lowering in People With and Without Chronic Kidney Disease: A Systematic Review and Meta-Analysis." Authors include Fotini Iatridi, Alistair J. Roddick, Natalie Staplin, and others.
@kidneyint.bsky.socialOct 6, 2026, 5:49 PM

The Renal Iohexol Clearance Survey examined whether testosterone is a risk factor for age-related measured glomerular filtration rate decline in males

doi.org/10.1016/j.kint.2026.07.030

#NephSky #MedSky #OpenAccess #CKD #chronickidneydisease #sexhormones #GFR @uitnorgesarktiske.bsky.social

@kidneyint.bsky.socialOct 6, 2026, 5:13 PM

Asia-Pacific summit on the implementation of clinical practice guidelines on #diabetes and blood pressure management in #chronickidneydisease: a Kidney Disease: Improving Global Outcomes ( #KDIGO) summit report

doi.org/10.1016/j.kint.2026.07.027

#NephSky #MedSky #OpenAccess #CKD #bloodpressure

@gmj-georgia.bsky.socialSep 24, 2026, 7:26 PM

New data: Chronic kidney disease affects 1 in 7 US adults—and the disease is changing. While overall CKD prevalence has remained stable at 15% over the past… #Chronickidneydisease #Diabetes #Epidemiology #Kidneyhealth #Publichealth #Chronickidneydisease #Diabetes #Epidemiology #Kidneyhealth #Pu…

@jamacardiology.comSep 23, 2026, 6:51 PM

Among patients with #HeartFailure and left ventricular ejection fraction ≥40%, undiagnosed #ChronicKidneyDisease was common and was associated with higher cardiovascular death and total heart failure event rates vs no chronic kidney disease.

ja.ma/4yPW4Wi

@jubleemediagroup.bsky.socialSep 17, 2026, 5:25 PM

You are allowed to be scared about what kidney disease could mean for your future...

and still be excited about what you're doing Saturday.

Those two things can exist together.

#LivingWithCKD #CKD #ChronicKidneyDisease #JubLeeMediaGroup #JubLeeMedia

@pharmaphorum.bsky.socialSep 17, 2026, 2:30 PM

#Bayer's #Kerendia has had its label extended in the #US to include #chronickidneydisease (CKD) associated with #type1diabetes (T1D), becoming the first new therapy for these patients in around 30 years.

buff.ly/KdEzX5U

@jmirlatestresearch.bsky.socialSep 10, 2026, 5:38 PM

JMIR Formative Res: Renaclic for Chronic Kidney Disease Self-Management: Formative User-Centered Co-Design Study #ChronicKidneyDisease #CKD #PatientEducation #DigitalHealth #SelfManagement

@genesndiseases.bsky.socialSep 10, 2026, 4:20 PM

Learn how betaine protects bone.
This study shows betaine blocks #ferroptosis, restores osteogenesis via the ABCG1–HMOX1 axis, and emerges as a promising therapy for #RenalOsteodystrophy. #ChronicKidneyDisease
#OpenAccess in #GenesAndDiseases: doi.org/10.1016/j.ge...

@jamanetworkopen.comSep 6, 2026, 3:00 PM

Among patients with #AtrialFibrillation and advanced #ChronicKidneyDisease not receiving dialysis, apixaban was associated with lower ischemic stroke risk and higher bleeding risk vs no anticoagulation, but lower bleeding and stroke risk vs warfarin.

ja.ma/4ibaM5n

Three forest plots with tables comparing drug outcomes. A: Apixaban vs no use shows increased GI bleeding but reduced death. B: Warfarin vs no use shows increased GI and intracranial bleeding but reduced death. C: Apixaban vs Warfarin shows Apixaban reduces all three outcomes.